Central Mechanisms involved in the interactions between muscle pain and exercise
参与肌肉疼痛和运动之间相互作用的中枢机制
基本信息
- 批准号:8292800
- 负责人:
- 金额:$ 46.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-04-06 至 2017-03-31
- 项目状态:已结题
- 来源:
- 关键词:Absence of pain sensationAcidsAcuteAcute PainAddressAffectAnalgesicsAnimal ModelAnimalsBrain StemCell NucleusCell membraneCellsChronicComplexDataDevelopmentExerciseGoalsHealth BenefitHyperalgesiaIndividualInjection of therapeutic agentIntramuscularLaboratoriesLinkMediatingModelingMotorMusMuscleMusculoskeletal PainMyalgiaN-Methyl-D-Aspartate ReceptorsNR1 NMDA receptorNR1 geneNeurobiologyNociceptionOpioidOpioid ReceptorPainPathway interactionsPeripheralPhosphorylationPhysical activityPreventionReceptor CellResearchRoleRunningSalineSpinal CordStimulusSympathetic Nervous SystemTestingTrainingWorkchronic painendogenous opioidsgenetic manipulationimprovedmouse developmentneural circuitnociceptive responsepain behaviorpreventprogramsresearch studyresponsesedentarytrafficking
项目摘要
DESCRIPTION (provided by applicant): Regular physical activity (exercise) can reduce pain in people with chronic musculoskeletal pain; whereas, unaccustomed exercise can exacerbate pain. This apparent dichotomy in pain response to physical activity is poorly understood, making exercise prescription for individuals with pain challenging. In sedentary mice, a single bout of exercise enhances the nociceptive response to subthreshold muscle stimuli (pH 5.0 saline); this enhancement is prevented by 5 days of voluntary running wheel activity. Further, in mice the development of chronic muscle pain, induced by repeated intramuscular acid (pH 4.0) injections, is prevented by 8 weeks of voluntary running wheel activity. Regular exercise is believed to activate central inhibitory pathways that produce an opioid-mediated analgesia; the rostral ventromedial medulla (RVM) is a key central nucleus in opioid-induced analgesia. However, little data is available to support a role for central opioid mechanisms in exercise-induced analgesia, particularly in conditions of chronic pain. Our preliminary data show that the analgesic effect of 8 weeks of running wheel activity (i.e. regular exercise) is reversed by systemic blockade of opioid receptors, establishing that opioids are important in regular exercise-induced analgesia. Our preliminary data show that there is increased p-NR1 (NMDA receptor) in the RVM in sedentary animals after a single-bout of exercise or induction chronic muscle pain. These increases in p-NR1 in the RVM, however, are prevented by regular exercise, suggesting that p-NR1 is modulated by mechanisms activated by exercise. These data led to our central hypothesis that regular exercise enhances activation of central inhibitory pathways that utilize endogenous opioids to modulate p-NR1 in the RVM. We will address our central aim through the following specific aims. Aim 1 will determine if regular physical activity (running wheel exercise) prevents the development of chronic muscle pain, and if such an effect is associated with motor and autonomic responses that might occur in response to exercise training and activation of the RVM. Aim 2 will determine if regular physical activity prevents the development of hyperalgesia by activation of opioid receptors. We will test this by pharmacological and genetic manipulation of opioid receptors. Aim 3 will explore the neural circuitry involved in the enhanced nociception to unaccustomed physical activity and the analgesia produced by regular physical activity. We will establish if NMDA receptors are located on and modulate pain facilitatory "ON cells" through m- opioid receptors (MOR), and if these cells project to the spinal cord. These studies will be the first to evaluate the effects of regula exercise on hyperalgesia and the underlying mechanisms that mediate these effects. Understanding these interactions will give us a better understanding of the underlying neurobiology to improve the overall management of people with chronic musculoskeletal pain, and prevention of development of chronic pain.
PUBLIC HEALTH RELEVANCE: Regular physical activity (exercise) can reduce pain in people with chronic musculoskeletal pain; whereas, unaccustomed exercise can exacerbate pain. This proposal aims to examine the central mechanisms underlying the effects of exercise on pain using recently developed animal models of exercise-induced pain, and exercise-induced analgesia. Understanding these interactions will give us a better understanding of the underlying neurobiology to improve the overall management of people with chronic musculoskeletal pain, and prevention of development of chronic pain.
描述(由申请人提供):定期进行体力活动(锻炼)可以减轻慢性肌肉骨骼疼痛患者的疼痛;然而,不习惯的运动会加剧疼痛。人们对身体活动对疼痛反应的这种明显的二分法知之甚少,这使得为疼痛患者制定运动处方具有挑战性。在久坐的小鼠中,单次运动可增强对阈下肌肉刺激(pH 5.0 盐水)的伤害性反应;这种增强是通过 5 天的自愿跑轮活动来阻止的。此外,在小鼠中,通过重复肌内注射酸(pH 4.0)引起的慢性肌肉疼痛的发展,可以通过 8 周的自愿跑轮活动来预防。定期运动被认为可以激活中枢抑制通路,从而产生阿片类药物介导的镇痛作用;延髓头端腹内侧(RVM)是阿片类药物诱导镇痛的关键中枢核。然而,很少有数据支持中枢阿片类药物机制在运动引起的镇痛中的作用,特别是在慢性疼痛的情况下。我们的初步数据表明,8周跑轮活动(即定期运动)的镇痛效果可通过阿片受体的全身阻断而逆转,这表明阿片类药物在定期运动引起的镇痛中很重要。我们的初步数据表明,在一次运动或诱发慢性肌肉疼痛后,久坐动物的 RVM 中 p-NR1(NMDA 受体)增加。然而,定期运动可以阻止 RVM 中 p-NR1 的增加,这表明 p-NR1 受到运动激活机制的调节。这些数据得出我们的中心假设,即定期运动可以增强中枢抑制途径的激活,利用内源性阿片类药物调节 RVM 中的 p-NR1。我们将通过以下具体目标来实现我们的中心目标。目标 1 将确定定期的体力活动(跑轮运动)是否可以预防慢性肌肉疼痛的发生,以及这种效应是否与运动训练和 RVM 激活时可能发生的运动和自主反应相关。目标 2 将确定定期体力活动是否可以通过激活阿片受体来防止痛觉过敏的发生。我们将通过阿片受体的药理学和基因操作来测试这一点。目标 3 将探索与不习惯的体力活动增强的伤害感受和常规体力活动产生的镇痛有关的神经回路。我们将确定 NMDA 受体是否位于并通过 m-阿片受体 (MOR) 调节疼痛促进“ON 细胞”,以及这些细胞是否投射到脊髓。这些研究将首次评估调节运动对痛觉过敏的影响以及介导这些影响的潜在机制。了解这些相互作用将使我们更好地了解潜在的神经生物学,从而改善慢性肌肉骨骼疼痛患者的整体管理,并预防慢性疼痛的发展。
公共卫生相关性:定期进行体力活动(锻炼)可以减轻慢性肌肉骨骼疼痛患者的疼痛;然而,不习惯的运动会加剧疼痛。该提案旨在利用最近开发的运动引起的疼痛和运动引起的镇痛的动物模型来研究运动对疼痛影响的核心机制。了解这些相互作用将使我们更好地了解潜在的神经生物学,从而改善慢性肌肉骨骼疼痛患者的整体管理,并预防慢性疼痛的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KATHLEEN A SLUKA其他文献
KATHLEEN A SLUKA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KATHLEEN A SLUKA', 18)}}的其他基金
Role of macrophages in activity-induced pain and analgesia
巨噬细胞在活动引起的疼痛和镇痛中的作用
- 批准号:
10615884 - 财政年份:2019
- 资助金额:
$ 46.84万 - 项目类别:
Role of macrophages in activity-induced pain and analgesia
巨噬细胞在活动引起的疼痛和镇痛中的作用
- 批准号:
10402776 - 财政年份:2019
- 资助金额:
$ 46.84万 - 项目类别:
Role of macrophages in activity-induced pain and analgesia
巨噬细胞在活动引起的疼痛和镇痛中的作用
- 批准号:
9914222 - 财政年份:2019
- 资助金额:
$ 46.84万 - 项目类别:
Central Mechanisms involved in the interactions between muscle pain and exercise
参与肌肉疼痛和运动之间相互作用的中枢机制
- 批准号:
8456081 - 财政年份:2012
- 资助金额:
$ 46.84万 - 项目类别:
Central Mechanisms involved in the interactions between muscle pain and exercise
参与肌肉疼痛和运动之间相互作用的中枢机制
- 批准号:
9044729 - 财政年份:2012
- 资助金额:
$ 46.84万 - 项目类别:
Central Mechanisms involved in the interactions between muscle pain and exercise
参与肌肉疼痛和运动之间相互作用的中枢机制
- 批准号:
8651896 - 财政年份:2012
- 资助金额:
$ 46.84万 - 项目类别:
Central Mechanisms involved in the interactions between muscle pain and exercise
参与肌肉疼痛和运动之间相互作用的中枢机制
- 批准号:
9094974 - 财政年份:2012
- 资助金额:
$ 46.84万 - 项目类别:
2012 American Pain Society Annual Scientific Meeting
2012年美国疼痛学会科学年会
- 批准号:
8317032 - 财政年份:2012
- 资助金额:
$ 46.84万 - 项目类别:
Central Mechanisms involved in the interactions between muscle pain and exercise
参与肌肉疼痛和运动之间相互作用的中枢机制
- 批准号:
8827245 - 财政年份:2012
- 资助金额:
$ 46.84万 - 项目类别:
相似国自然基金
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
- 批准号:22007039
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
- 批准号:
- 批准年份:2019
- 资助金额:10.0 万元
- 项目类别:省市级项目
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
- 批准号:21372217
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
- 批准号:21172061
- 批准年份:2011
- 资助金额:30.0 万元
- 项目类别:面上项目
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
- 批准号:21176225
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
- 批准号:81072511
- 批准年份:2010
- 资助金额:31.0 万元
- 项目类别:面上项目
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
- 批准号:30660215
- 批准年份:2006
- 资助金额:21.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Gene expression regulation in recurrent paediatric acute myeloid leukaemia by characterization of non-coding ribonucleic acids
通过非编码核糖核酸的表征研究复发性小儿急性髓性白血病的基因表达调控
- 批准号:
449784 - 财政年份:2020
- 资助金额:
$ 46.84万 - 项目类别:
Studentship Programs
Study of metabolism of sulfur-containing amino acids as anti-oxidant against the acute exacerbation of interstitial pneumonia
含硫氨基酸抗氧化代谢对间质性肺炎急性加重的研究
- 批准号:
16K19984 - 财政年份:2016
- 资助金额:
$ 46.84万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Omega 3 Fatty Acids Acute Neuroprotection via Mitochondria
Omega 3 脂肪酸通过线粒体提供急性神经保护作用
- 批准号:
9450547 - 财政年份:2015
- 资助金额:
$ 46.84万 - 项目类别:
Omega 3 fatty acids, acute neuroprotection via mitochondria
Omega 3 脂肪酸,通过线粒体提供急性神经保护
- 批准号:
10447712 - 财政年份:2015
- 资助金额:
$ 46.84万 - 项目类别:
Omega 3 fatty acids, acute neuroprotection via mitochondria
Omega 3 脂肪酸,通过线粒体提供急性神经保护
- 批准号:
10297604 - 财政年份:2015
- 资助金额:
$ 46.84万 - 项目类别:
Omega 3 Fatty Acids, Acute Neuroprotection Via Mitochondria
Omega 3 脂肪酸,通过线粒体提供急性神经保护
- 批准号:
10655664 - 财政年份:2015
- 资助金额:
$ 46.84万 - 项目类别:
Omega 3 Fatty Acids Acute Neuroprotection via Mitochondria
Omega 3 脂肪酸通过线粒体提供急性神经保护作用
- 批准号:
8996605 - 财政年份:2015
- 资助金额:
$ 46.84万 - 项目类别:
ACUTE EFFECTS OF OLANZAPINE ON PLASMA LEPTIN, GLUCOSE TOLERANCE FREE FATTY ACIDS
奥氮平对血浆瘦素、无葡萄糖耐量脂肪酸的急性影响
- 批准号:
7951282 - 财政年份:2009
- 资助金额:
$ 46.84万 - 项目类别:
SENSITIVITY TO ACUTE INSULIN MEDIATED SUPPRESSION OF PLASMA FREE FATTY ACIDS
对胰岛素介导的血浆游离脂肪酸急性抑制的敏感性
- 批准号:
7180051 - 财政年份:2005
- 资助金额:
$ 46.84万 - 项目类别:
SENSITIVITY TO ACUTE INSULIN MEDIATED SUPPRESSION OF PLASMA FREE FATTY ACIDS
对胰岛素介导的血浆游离脂肪酸急性抑制的敏感性
- 批准号:
6977013 - 财政年份:2003
- 资助金额:
$ 46.84万 - 项目类别: